Several rare variants in TREM2, such as TREM2R47H, have emerged and significantly increased the risk by 2- to 4-fold, comparable to the increased risk associated with having one copy of APOEε4, which impairs ligand binding and curtails microglial activation in humans and AD mouse models[74]. The gene discussed is TREM2; the disease is Alzheimer disease.